Pegylated interferon: New progress in treatment for chronic hepatitis C;L'interferon pegyle: Nouveau progres dans le traitement de l'hepatite chronique virale C

Gastroenterologie Clinique et Biologique

Volumn 24, Issue 8-9, 2000, Pages 767-769

  Boyer, N ^a   Marcellin, P ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MACROGOL; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A; PEGINTERFERON ALFA-2B; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B;

CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG STRUCTURE; DRUG TOLERABILITY; HEPATITIS C; HUMAN; IMMUNOTHERAPY; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; CHEMISTRY;

ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; POLYETHYLENE GLYCOLS; TREATMENT OUTCOME;

EID: 0033779064     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Resultats du traitement de l'hepatite C par l'interferon seul ou en association a d'autres medicaments
2. Traitement de l'hepatite C par l'interferon
3. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
4. Randomised trial of interferon alfa 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alfa 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
5. Conference internationale de consensus sur l'hepatite C. Conclusions
6. Hepatitis C virus kinetics in chronically infected patients treated with pegylated interferon-alfa
7. Pathogenesis, diagnosis and management of hepatitis
8. Variabilite genetique du virus de l'hepatite C
9. Genetic complexity of the hypervariable region I (HVRI) of hepatitis C virus: Influence on the characteristics of the infection and the response to alpha-interferon therapy in patients with chronic hepatitis C
10. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alpha
11. Use of high-dose interferon in the treatment of chronic hepatitis C
12. Pegylated interferon alfa-2b (PEG-Intron) monotherapy is superior to interferon alfa-2b (Intron A) for the treatment of chronic hepatitis C
13. Evaluation of the safety and efficacy of once-weekly PEG/interferon alfa-2a (Pegasys(TM)) for chronic hepatitis C. A multinational, randomized study
14. The pharmacokinetics of pegylated-40k interferon alfa-2a (PEG-IFN) in chronic hepatitis C (CHC) patients with cirrhosis